Hunan Jingfeng Pharmaceutical (000908) — Net Asset Momentum
Hunan Jingfeng Pharmaceutical (000908) recorded a net asset momentum of 90.2% as of December 2024, with net assets of CN¥-15.13 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see Hunan Jingfeng Pharmaceutical stock valuation.
YoY Momentum
Current Net Assets
Years of Data
Country
Hunan Jingfeng Pharmaceutical Net Asset Momentum (1995–2024)
This chart tracks Hunan Jingfeng Pharmaceutical's year-over-year net asset growth across 30 annual reporting periods from 1995 to 2024. The most recent momentum reading is +90.2%, with net assets of CN¥-15.13 Million CNY as of December 2024. Check asset allocation strategy of Hunan Jingfeng Pharmaceutical to assess the company's strategic physical and investment asset allocation.
Annual Net Asset History for Hunan Jingfeng Pharmaceutical (1995–2024)
The table below shows the complete annual net asset history for Hunan Jingfeng Pharmaceutical from 1995 to 2024, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 000908 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥-15.13 Million | CN¥939.98 Million | CN¥955.11 Million | ▲ +90.2% |
| 2023 | CN¥-153.68 Million | CN¥1.06 Billion | CN¥1.21 Billion | ▼ -171.5% |
| 2022 | CN¥214.83 Million | CN¥1.47 Billion | CN¥1.25 Billion | ▼ -34.4% |
| 2021 | CN¥327.73 Million | CN¥1.79 Billion | CN¥1.46 Billion | ▼ -48.6% |
| 2020 | CN¥638.18 Million | CN¥2.69 Billion | CN¥2.05 Billion | ▼ -67.1% |
| 2019 | CN¥1.94 Billion | CN¥4.35 Billion | CN¥2.41 Billion | ▼ -32.2% |
| 2018 | CN¥2.86 Billion | CN¥5.23 Billion | CN¥2.37 Billion | ▲ +10.1% |
| 2017 | CN¥2.60 Billion | CN¥4.87 Billion | CN¥2.27 Billion | ▼ -0.5% |
| 2016 | CN¥2.61 Billion | CN¥5.13 Billion | CN¥2.52 Billion | ▲ +16.2% |
| 2015 | CN¥2.25 Billion | CN¥3.44 Billion | CN¥1.19 Billion | ▲ +126.2% |
| 2014 | CN¥994.04 Million | CN¥1.91 Billion | CN¥919.76 Million | ▲ +18625.0% |
| 2013 | CN¥5.31 Million | CN¥336.78 Million | CN¥331.47 Million | ▲ +108.8% |
| 2012 | CN¥-60.15 Million | CN¥370.13 Million | CN¥430.29 Million | ▼ -7706.7% |
| 2011 | CN¥790.82K | CN¥421.45 Million | CN¥420.66 Million | ▼ -98.6% |
| 2010 | CN¥57.85 Million | CN¥471.37 Million | CN¥413.53 Million | ▼ -42.5% |
| 2009 | CN¥100.67 Million | CN¥784.81 Million | CN¥684.14 Million | ▼ -70.3% |
| 2008 | CN¥338.64 Million | CN¥989.24 Million | CN¥650.60 Million | ▲ +0.5% |
| 2007 | CN¥336.95 Million | CN¥814.38 Million | CN¥477.43 Million | ▲ +0.2% |
| 2006 | CN¥336.40 Million | CN¥822.47 Million | CN¥486.08 Million | ▲ +2.0% |
| 2005 | CN¥329.66 Million | CN¥840.14 Million | CN¥510.48 Million | ▼ -2.9% |
| 2004 | CN¥339.45 Million | CN¥889.56 Million | CN¥550.11 Million | ▼ -19.1% |
| 2003 | CN¥419.38 Million | CN¥983.02 Million | CN¥563.64 Million | ▼ -19.8% |
| 2002 | CN¥522.69 Million | CN¥866.67 Million | CN¥343.98 Million | ▲ +4.9% |
| 2001 | CN¥498.41 Million | CN¥620.88 Million | CN¥122.47 Million | ▼ -0.4% |
| 2000 | CN¥500.54 Million | CN¥697.92 Million | CN¥197.38 Million | ▲ +3.1% |
| 1999 | CN¥485.43 Million | CN¥691.94 Million | CN¥206.51 Million | ▲ +21.2% |
| 1998 | CN¥400.62 Million | CN¥473.15 Million | CN¥72.54 Million | ▲ +363.1% |
| 1997 | CN¥86.51 Million | CN¥132.21 Million | CN¥45.70 Million | ▲ +42.2% |
| 1996 | CN¥60.83 Million | CN¥131.54 Million | CN¥70.71 Million | ▲ +97.5% |
| 1995 | CN¥30.79 Million | CN¥66.33 Million | CN¥35.54 Million | — |